Tissue transcriptome-driven identification of epidermal growth factor as a chronic kidney disease biomarker.

PubWeight™: 1.03‹?› | Rank: Top 15%

🔗 View Article (PMID 26631632)

Published in Sci Transl Med on December 02, 2015

Authors

Wenjun Ju1,2, Viji Nair1, Shahaan Smith1, Li Zhu3, Kerby Shedden2,4, Peter X K Song5, Laura H Mariani1,6, Felix H Eichinger1, Celine C Berthier1, Ann Randolph1, Jennifer Yi-Chun Lai1, Yan Zhou5, Jennifer J Hawkins1, Markus Bitzer1, Matthew G Sampson7, Martina Thier8, Corinne Solier8, Gonzalo C Duran-Pacheco8, Guillemette Duchateau-Nguyen8, Laurent Essioux8, Brigitte Schott8, Ivan Formentini8, Maria C Magnone8, Maria Bobadilla8, Clemens D Cohen9, Serena M Bagnasco10, Laura Barisoni11, Jicheng Lv3, Hong Zhang3, Hai-Yan Wang3, Frank C Brosius1,12, Crystal A Gadegbeku13, Matthias Kretzler1,2, ERCB, C-PROBE, NEPTUNE, and PKU-IgAN Consortium

Author Affiliations

1: Department of Internal Medicine, University of Michigan, Ann Arbor, MI 48109, USA.
2: Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI 48109, USA.
3: Renal Division, Department of Internal Medicine, Peking University First Hospital, Peking University Institute of Nephrology, Beijing 100034, China.
4: Department of Statistics, University of Michigan, Ann Arbor, MI 48109, USA.
5: Department of Biostatistics, University of Michigan, Ann Arbor, MI 48109, USA.
6: Arbor Research Collaborative for Health, Ann Arbor, MI 48104, USA.
7: Department of Pediatrics, University of Michigan, Ann Arbor, MI 48109, USA.
8: Roche Pharmaceutical Research and Early Development-Roche Innovation Center, 4070 Basel, Switzerland.
9: Division of Nephrology, Institute of Physiology, University of Zurich, CH-8006 Zürich, Switzerland.
10: Department of Pathology, Johns Hopkins School of Medicine, Baltimore, MD 21287, USA.
11: Department of Pathology, Miller School of Medicine, University of Miami, Miami, FL 33136, USA.
12: Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, MI 48109, USA.
13: Temple Clinical Research Institute, Temple University School of Medicine, Philadelphia, PA 19140, USA.

Articles citing this

Synaptopodin Is a Coincidence Detector of Tyrosine versus Serine/Threonine Phosphorylation for the Modulation of Rho Protein Crosstalk in Podocytes. J Am Soc Nephrol (2016) 1.40

Defining Glomerular Disease in Mechanistic Terms: Implementing an Integrative Biology Approach in Nephrology. Clin J Am Soc Nephrol (2016) 0.82

EGF receptor ligands: recent advances. F1000Res (2016) 0.77

Biomarkers for the Early Detection and Prognosis of Acute Kidney Injury. Clin J Am Soc Nephrol (2016) 0.77

Epidermal growth factor as a prognostic biomarker in chronic kidney diseases. Ann Transl Med (2016) 0.75

Drug discovery in focal and segmental glomerulosclerosis. Kidney Int (2016) 0.75

Serum amyloid a and risk of death and end-stage renal disease in diabetic kidney disease. J Diabetes Complications (2016) 0.75

A systems approach to renal inflammation in SLE. Clin Immunol (2016) 0.75

Assessment of Urine Proteomics in Type 1 Primary Hyperoxaluria. Am J Nephrol (2016) 0.75

Progression of chronic kidney disease: too much cellular talk causes damage. Kidney Int (2016) 0.75

Urine biomarkers of tubular injury do not improve on the clinical model predicting chronic kidney disease progression. Kidney Int (2016) 0.75

Glomerular disease: Personalized immunomonitoring in lupus and lupus nephritis. Nat Rev Nephrol (2016) 0.75

Proteomics for prediction of disease progression and response to therapy in diabetic kidney disease. Diabetologia (2016) 0.75

Renal disease pathophysiology and treatment: contributions from the rat. Dis Model Mech (2016) 0.75

Podocytes and the quest for precision medicines for kidney diseases. Pflugers Arch (2017) 0.75

Transcriptomic and Proteomic Profiling Provides Insight into Mesangial Cell Function in IgA Nephropathy. J Am Soc Nephrol (2017) 0.75

Opportunities and challenges in phenotypic drug discovery: an industry perspective. Nat Rev Drug Discov (2017) 0.75

Renal biopsy-driven molecular target identification in glomerular disease. Pflugers Arch (2017) 0.75

The loss of Krüppel-like factor 15 in Foxd1(+) stromal cells exacerbates kidney fibrosis. Kidney Int (2017) 0.75

Articles cited by this

K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis (2002) 81.62

Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet (2012) 56.72

Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med (2006) 32.81

Prevalence of chronic kidney disease in China: a cross-sectional survey. Lancet (2012) 10.53

Chronic kidney disease: global dimension and perspectives. Lancet (2013) 8.16

Modified glomerular filtration rate estimating equation for Chinese patients with chronic kidney disease. J Am Soc Nephrol (2006) 8.05

Chronic kidney disease as a global public health problem: approaches and initiatives - a position statement from Kidney Disease Improving Global Outcomes. Kidney Int (2007) 7.75

Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA (2012) 6.26

Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease. N Engl J Med (1982) 5.65

Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol (2004) 5.23

Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules. Pharm Res (2003) 4.54

Predictors of the progression of renal disease in the Modification of Diet in Renal Disease Study. Kidney Int (1997) 4.22

Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA (2014) 3.53

Modular activation of nuclear factor-kappaB transcriptional programs in human diabetic nephropathy. Diabetes (2006) 2.85

Circulating TNF receptors 1 and 2 predict stage 3 CKD in type 1 diabetes. J Am Soc Nephrol (2012) 2.58

Longitudinal progression trajectory of GFR among patients with CKD. Am J Kidney Dis (2012) 2.51

Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application. Kidney Int (2002) 2.34

The ratio of epidermal growth factor to monocyte chemotactic peptide-1 in the urine predicts renal prognosis in IgA nephropathy. Kidney Int (2007) 2.31

High-normal serum uric acid increases risk of early progressive renal function loss in type 1 diabetes: results of a 6-year follow-up. Diabetes Care (2010) 2.12

Defining cell-type specificity at the transcriptional level in human disease. Genome Res (2013) 1.96

Gene expression in the normal adult human kidney assessed by complementary DNA microarray. Mol Biol Cell (2003) 1.79

Epidermal growth factor enhances renal tubule cell regeneration and repair and accelerates the recovery of renal function in postischemic acute renal failure. J Clin Invest (1989) 1.73

Integrative biology identifies shared transcriptional networks in CKD. J Am Soc Nephrol (2014) 1.71

Design of the Nephrotic Syndrome Study Network (NEPTUNE) to evaluate primary glomerular nephropathy by a multidisciplinary approach. Kidney Int (2013) 1.69

Renal histologic changes and the outcome in patients with diabetic nephropathy. Nephrol Dial Transplant (2014) 1.56

Mechanisms of progression of chronic kidney disease. Pediatr Nephrol (2007) 1.52

Renal interstitial fibrosis: mechanisms and evaluation. Curr Opin Nephrol Hypertens (2012) 1.46

Tubulointerstitial injury and the progression of chronic kidney disease. Pediatr Nephrol (2011) 1.37

Matrix metalloproteinase-7 as a surrogate marker predicts renal Wnt/β-catenin activity in CKD. J Am Soc Nephrol (2011) 1.32

Digital pathology evaluation in the multicenter Nephrotic Syndrome Study Network (NEPTUNE). Clin J Am Soc Nephrol (2013) 1.24

Cross-species transcriptional network analysis defines shared inflammatory responses in murine and human lupus nephritis. J Immunol (2012) 1.21

CKD and sudden cardiac death: epidemiology, mechanisms, and therapeutic approaches. J Am Soc Nephrol (2012) 1.20

MCP-1 and EGF renal expression and urine excretion in human congenital obstructive nephropathy. Kidney Int (2000) 1.20

Correlation of quantitative digital image analysis with the glomerular filtration rate in chronic allograft nephropathy. Am J Transplant (2004) 1.10

Urinary MCP-1 and RBP: independent predictors of renal outcome in macroalbuminuric diabetic nephropathy. J Diabetes Complications (2012) 1.09

Gene expression profiling analysis in nephrology: towards molecular definition of renal disease. Clin Exp Nephrol (2006) 1.07

Efficient estimation for patient-specific rates of disease progression using nonnormal linear mixed models. Biometrics (2007) 1.05

Epidermal growth factor receptor signaling in the kidney: key roles in physiology and disease. Hypertension (2008) 1.05

A toolbox of novel murine house-keeping genes identified by meta-analysis of large scale gene expression profiles. Biochim Biophys Acta (2008) 1.04

A molecular signature of proteinuria in glomerulonephritis. PLoS One (2010) 1.03

Early protocol renal allograft biopsies and graft outcome. Kidney Int (1997) 1.02

Reduced renal prepro-epidermal growth factor mRNA and decreased EGF excretion in ARF. Kidney Int (1989) 0.96

Urinary IL-6/EGF ratio: a useful prognostic marker for the progression of renal damage in IgA nephropathy. Kidney Int (1996) 0.91

Excretion of epidermal growth factor in human adult polycystic kidney disease. Isr J Med Sci (1997) 0.84

Expression of epidermal growth factor in the rat kidney. An immunocytochemical and in situ hybridization study. Histochemistry (1991) 0.84

Urinary epidermal growth factor is excreted from the rat isolated perfused kidney in the absence of plasma. J Endocrinol (1993) 0.81

Reduced urinary excretion of epidermal growth factor in incipient and overt diabetic nephropathy. Diabet Med (1989) 0.81

Early measurement of interstitial fibrosis predicts long-term renal function and graft survival in renal transplantation. Br J Surg (1996) 0.80

Human epidermal growth factor: renal production and absence from plasma. Regul Pept (1988) 0.79

Circulating TNF receptor 2 is closely associated with the kidney function in non-diabetic Japanese subjects. J Atheroscler Thromb (2014) 0.78

Urinary epidermal growth factor excretion in children with chronic renal failure. Am J Nephrol (1999) 0.77

Opposing roles of EGF in IFN-alpha-induced epithelial barrier destabilization and tissue repair. Am J Physiol Cell Physiol (2007) 0.77

Risk factors associated with the deterioration of renal function: the role of protocol biopsies. Prilozi (2007) 0.77